Category: Analyst’s Comments
Analyst's Comments

OneSmart International Education Group Ltd. (ONE) Stock Slid on Monday, Here’s the Reason

 OneSmart International Education Group Ltd. (ONE), a company that provides tutoring services for students, has surged 18.75% in aftermarket trading session. Consequently, ONE is trading at $0.23 at the time of the writing. On Monday, ONE closed the day at $0.19 after slumping 33.09% during the regular trading session. The massive side could be attributed to the receipt of notification from NYSE regarding the delayed filing of Form 20-F. Why ONE Declined? On Monday, ONE announced that it had received a notice from NYSE regulation. The notice indicated that the company is not complying with Section 802.01E of the NYSE Listed Company
Analyst's Comments

ATA Creativity Global (AACG) Stock in Decline After a Hefty Friday, Here’s Why

ATA Creativity Global (AACG), a company that provides educational services to individual students through its training centre network in China, has plunged 8.33% in aftermarket trading session. Consequently, AACG stock is trading at $2.42 at the time of the writing. The decline could be attributed to the profit-taking effect after the stock rocketed 33.33% during Friday’s regular trading session and closed the day at $2.64. The increase could be attributed to a huge volume of short-term trading, which is rampant with stock since the last month of the previous year. Q3 2021 Operational Results In early November, AACG released the operational

AMZN Stock
Analyst's Comments

Curis, Inc. (CRIS) Stock Slid on Thursday, Here’s the Reason

Curis, Inc. (CRIS), a biotechnology company, has increased by 5.58% in aftermarket trading session. Consequently, the stock is trading at $3.69 at the time of the writing. On Thursday, CRIS closed the day at $3.50 after plummeting 27.64% during regular trading hours. The plunge came despite the announcement of positive updated data from the phase ½ study of CA-4948. Positive Data from CRIS Study On Thursday, CRIS announced the positive updated clinical data from its ongoing Phase 1/2 dose-escalation and expansion study of CA-4948. CA-4948 is the novel and small molecule IRAK-4 inhibitor. It serves as a monotherapy in patients with relapsed
Analyst's Comments

RealReal, Inc. (REAL) Stock Declined on Wednesday, Here’s the Reason

RealReal, Inc. (REAL), an online marketplace for consigned luxury goods, has slightly increased by 0.97% in the premarket trading session. Consequently, REAL stock is trading at $11.48 at the time of the writing. On Wednesday, the REAL stock closed the day at $11.37 after declining 7.94% during the regular trading session. The decline came after the company announced its monthly business update. REAL Monthly Business Update On Wednesday, REAL announced its monthly business update for December. The Gross Merchandise Value (GMV) for the month stood at $153 million. That depicts an increase of 40% from the same period of 2020. The Average
Analyst's Comments

Calyxt, Inc. (CLXT) Stock Rose on Monday, Here’s the Reason

Calyxt, Inc. (CLXT), a technology company, is trading at $2.46 in the aftermarket at the time of the writing. On Tuesday, CLXT closed the day at $2.46 after surging 7.42% during regular trading hours. The surge could be attributed to the company’s announcement regarding the presentation. Why CLXT Surged? On Tuesday, CLXT announced that the higher management of the company would present at the H.C Wainwright BioConnect Conference. The conference would take place on the 10th of January, 2022. The conference would be held in the virtual meeting format, where the company would highlight some of the milestones it has achieved in

MPWR Stock
Analyst's Comments

Indaptus Therapeutics, Inc. (INDP) Stock on an Increasing Trajectory, Here’s Why

Indaptus Therapeutics, Inc. (INDP), a pre-clinical stage biotech company, has surged 17.02% in aftermarket trading session. Consequently, INDP stock is trading at $7.22 at the time of the writing. On Monday, INDP closed the day at $6.17 after soaring 8.25% in regular trading hours. The consistent increase could be attributed to the appointment of a new Chief Medical Officer. Why INDP Soaring? On Monday, INDP announced the appointment of Dr Boyan Litchev, M.D., as Chief Medical Officer. The appointment would become effective from 31st January 2022. Dr Litchev would take care of clinical strategy, clinical development as well as would conduct all
Analyst's Comments

Exicure, Inc. (XCUR) Stock Rising in Aftermarket Trading Session

Exicure, Inc. (XCUR), a clinical-stage biotechnology company, has surged 8.86% in aftermarket trading session. As a result, XCUR stock is trading at $0.22 at the time of the writing. On Friday, XCUR closed the day at $0.20 after increasing by 3.32% during the regular trading session. The increase in stock has come amid the investigations against the company regarding the violation of federal securities law. Investigations Against XCUR The investigations against XCUR are based on the complaint that the company had made false and misleading statements to the market. The company’s preclinical program for the treatment of Friedreichs ataxia suffered from numerous
Analyst's Comments

Realty Income Corp. (O) Stock Slightly decreased in Aftermarket Trading Session

Realty Income Corp. (O), a Real Estate Investment Trust that provides monthly dividends to investors, has slightly declined by 0.028% in the aftermarket trading session. As a consequence, O stock is trading at $71.89 at the time of the writing. On Thursday, O closed the day at $71.91 after nominally increasing by 0.014% during regular trading hours. The stock has consistently delivered some outstanding returns, primarily due to the fact that it provides monthly dividends to the shareholders. Let’s dive deeper into some developments of O stock. Realty IncomeCorp.: Q3 2021 Operational Results In early November, O released the operational results
Analyst's Comments

Professional Diversity Network, Inc. (IPDN) Stock Steadily Sliding, Here’s the Potential Reason

Professional Diversity Network, Inc. (IPDN), a company that operates online professional networking communities with career resources, has declined by 2.91% in the premarket trading session. As a result, IPDN stock is trading at $1.00 at the time of the writing. The decline could be attributed to short selling by certain investors as the stock has been on a gaining trajectory for quite some time. On Wednesday, IPDN closed the day at $1.03 after a surge of 6.17% during regular trading hours. Q3 2021 Operational Results On 16th November, IPDN released the operational results for the third quarter of the fiscal year
Analyst's Comments

Sutro Biopharma, Inc. (STRO) Stock on a Consistently Rising Trajectory, Here’s the Reason

Sutro Biopharma, Inc. (STRO), a clinical-stage drug discovery, development, and manufacturing company, has surged 6.38% in the premarket trading session. Consequently, STRO stock is trading at $15.50 at the time of the writing. On Monday, the stock closed the day at $14.57 after gaining an increase of 2.25%. The consistent increase could be attributed to the agreement between Sutro Biopharma and Tasly Biopharmaceuticals. Why STRO Rising? On Monday, Sutro Biopharma announced to have entered into an exclusive license agreement with Tasly Biopharmaceuticals, a holding subsidiary of Tasly Pharmaceutical Group Co., Ltd., for the development and commercialization of STRO-002 in mainland

News IMC are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Quick Links

Categories

©2024, Fueled by Smart TechOne